Deglycosylated and desialidated long pentraxin PTX3
AssigneeSigma-Tau Industrie Farmaceutiche Riunite S.p.A.
InventorsPaolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori
Life of this patent
Estimating the term…
Abstract
Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
Claims25
Functionally active deglycosylated long pentraxin PTX3.
Combination of functionally active deglycosylated long pentraxin PTX3 with an antifungal agent.
Dependencies are inferred from the claim text.